2026 Q3 Portfolio Activity
In 2026 Q3, Soleus Capital Management, L.P. maintained a portfolio of 124 distinct positions. The most significant new addition was ZAI LAB LTD, now representing 1.44% of the total fund value. They heavily accumulated shares in INSULET CORP, increasing the position by 64.6%. Conversely, Soleus Capital Management, L.P. completely exited their position in INDIVIOR PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
Total Positions
124
Quarter
2026 Q3
Top Holding
KRYS (13.5%)
Top 10 Concentration
53.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 124
Soleus Capital Management, L.P. Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 13.47% | 12.03% |
#1
Prev: #1
|
8.5 |
—
|
200,446 | 21.3% |
P
S
|
1,139,700 | $379,018,632 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PODD
INSULET CORP
|
Healthcare | 8.01% | 5.50% |
#2
2
Prev: #4
|
7.7 |
—
|
677,500 | 64.6% |
P
S
|
1,726,500 | $225,256,455 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NVCR
NOVOCURE LTD
|
Healthcare | 5.34% | 5.18% |
#3
2
Prev: #5
|
3.6 |
—
|
-487,625 | -4.9% |
P
S
|
9,425,776 | $150,341,127 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 5.07% | 5.54% |
#4
1
Prev: #3
|
3.0 |
—
|
-371,727 | -12.7% |
P
S
|
2,556,168 | $142,583,051 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 4.99% | 4.21% |
#5
1
Prev: #6
|
4.5 |
—
|
33,413 | 14.8% |
P
S
|
259,000 | $140,349,510 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CELC
CELCUITY INC
|
Healthcare | 4.76% | 6.14% |
#6
4
Prev: #2
|
2.4 |
—
|
-21,558 | -1.3% |
P
S
|
1,682,760 | $133,813,075 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RIGL
RIGEL PHARMACEU...
|
Healthcare | 3.16% | 2.49% |
#7
1
Prev: #8
|
2.3 |
—
|
no change | no change |
P
S
|
1,843,504 | $88,764,718 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 2.98% | 2.97% |
#8
1
Prev: #7
|
1.2 |
—
|
-724,608 | -37.5% |
P
S
|
1,206,828 | $83,705,590 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ERAS
ERASCA INC
|
Healthcare | 2.66% | 1.70% |
#9
6
Prev: #15
|
4.1 |
—
|
2,412,000 | 89.3% |
P
S
|
5,112,000 | $74,941,920 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BBNX
BETA BIONICS IN...
|
Healthcare | 2.53% | 2.37% |
#10
Prev: #10
|
1.5 |
—
|
-650,000 | -14.8% |
P
S
|
3,743,714 | $71,055,692 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 2.52% | 2.48% |
#11
2
Prev: #9
|
3.0 |
—
|
107,740 | 12.4% |
P
S
|
975,500 | $70,870,075 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VCEL
VERICEL CORP
|
Healthcare | 2.22% | 2.24% |
#12
1
Prev: #11
|
2.9 |
—
|
94,907 | 6.5% |
P
S
|
1,554,059 | $62,379,928 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GERN
GERON CORP
|
Healthcare | 2.04% | 1.89% |
#13
Prev: #13
|
2.8 |
—
|
3,960,000 | 9.3% |
P
S
|
46,768,659 | $57,525,451 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PBLS
PARABILIS MEDIC...
|
Healthcare | 1.93% | 1.38% |
#14
5
Prev: #19
|
2.8 |
—
|
219,442 | 15.0% |
P
S
|
1,684,512 | $54,392,892 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARGX
ARGENX SE
|
Healthcare | 1.68% | 0.64% |
#15
26
Prev: #41
|
3.7 |
—
|
29,395 | 147.3% |
P
S
|
49,350 | $47,322,209 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AXGN
AXOGEN INC
|
Healthcare | 1.61% | 0.09% |
#16
66
Prev: #82
|
3.6 |
—
|
1,023,964 | 1795.3% |
P
S
|
1,081,000 | $45,315,520 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NPCE
NEUROPACE INC
|
Healthcare | 1.57% | 1.59% |
#17
1
Prev: #16
|
2.6 |
—
|
306,878 | 10.5% |
P
S
|
3,218,000 | $44,279,680 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 1.45% | 0.20% |
#18
56
Prev: #74
|
3.6 |
—
|
4,267,572 | 518.9% |
P
S
|
5,090,000 | $40,720,000 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 1.44% | — |
#19
Prev: #—
|
4.1 |
—
|
1,543,000 | — |
NEW
|
1,543,000 | $40,642,620 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PGNY
PROGYNY INC
|
Healthcare | 1.42% | 1.59% |
#20
3
Prev: #17
|
1.1 |
—
|
-20,000 | -1.2% |
P
S
|
1,582,000 | $39,850,580 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 1.39% | 0.76% |
#21
17
Prev: #38
|
3.6 |
—
|
1,548,109 | 131.2% |
P
S
|
2,727,727 | $39,061,051 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NVCT
NUVECTIS PHARMA...
|
Healthcare | 1.28% | 0.63% |
#22
20
Prev: #42
|
3.5 |
—
|
710,658 | 71.1% |
P
S
|
1,710,658 | $36,129,097 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EDAP
EDAP TMS S A
|
Healthcare | 1.16% | 1.30% |
#23
3
Prev: #20
|
1.5 |
—
|
no change | no change |
P
S
|
7,309,254 | $32,672,365 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVLN
AVALYN PHARMACE...
|
Healthcare | 1.03% | 0.48% |
#24
26
Prev: #50
|
3.4 |
—
|
600,000 | 143.2% |
P
S
|
1,019,000 | $29,031,310 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 0.97% | — |
#25
Prev: #—
|
3.9 |
—
|
286,966 | — |
NEW
|
286,966 | $27,204,377 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 0.93% | 0.24% |
#26
42
Prev: #68
|
3.4 |
—
|
1,755,700 | 278.7% |
P
S
|
2,385,700 | $26,075,701 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 0.82% | 0.76% |
#27
10
Prev: #37
|
0.8 |
—
|
350,000 | 3.2% |
P
S
|
11,225,000 | $23,067,375 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 0.79% | 1.24% |
#28
6
Prev: #22
|
0.3 |
—
|
-306,738 | -26.2% |
P
S
|
862,000 | $22,265,460 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 0.77% | 1.20% |
#29
4
Prev: #25
|
0.8 |
—
|
-119,450 | -9.9% |
P
S
|
1,085,550 | $21,591,590 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.75% | 1.22% |
#30
6
Prev: #24
|
0.3 |
—
|
-573,000 | -39.1% |
P
S
|
892,163 | $21,153,185 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 0.75% | — |
#31
Prev: #—
|
3.8 |
—
|
210,000 | — |
NEW
|
210,000 | $21,016,800 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANL
ADLAI NORTYE GR...
|
Healthcare | 0.72% | 0.16% |
#32
43
Prev: #75
|
3.3 |
—
|
866,832 | 213.8% |
P
S
|
1,272,355 | $20,357,680 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 0.72% | 0.94% |
#33
2
Prev: #31
|
2.3 |
—
|
1,932,467 | 14.8% |
P
S
|
14,996,154 | $20,244,808 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.72% | 1.86% |
#34
20
Prev: #14
|
0.3 |
—
|
-531,546 | -51.6% |
P
S
|
497,706 | $20,167,047 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 0.71% | 0.76% |
#35
1
Prev: #36
|
2.3 |
—
|
93,297 | 13.2% |
P
S
|
802,297 | $20,017,310 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BDSX
BIODESIX INC
|
Healthcare | 0.71% | 0.46% |
#36
15
Prev: #51
|
2.3 |
—
|
81,877 | 14.0% |
P
S
|
667,835 | $19,921,518 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 0.68% | 0.87% |
#37
5
Prev: #32
|
0.8 |
—
|
-126,907 | -17.4% |
P
S
|
604,000 | $19,158,880 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INSM
INSMED INC
|
Healthcare | 0.60% | 0.33% |
#38
19
Prev: #57
|
3.2 |
—
|
56,750 | 62.9% |
P
S
|
147,000 | $16,778,580 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 0.59% | 2.05% |
#39
27
Prev: #12
|
0.2 |
—
|
-121,002 | -68.2% |
P
S
|
56,515 | $16,458,863 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 0.58% | 1.19% |
#40
14
Prev: #26
|
0.2 |
—
|
-379,762 | -24.5% |
P
S
|
1,170,928 | $16,451,538 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KNSA
KINIKSA PHARMAC...
|
Healthcare | 0.58% | 0.54% |
#41
7
Prev: #48
|
0.7 |
—
|
-27,395 | -11.1% |
P
S
|
218,958 | $16,336,456 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CNMD
CONMED CORP
|
Healthcare | 0.57% | — |
#42
Prev: #—
|
3.7 |
—
|
347,333 | — |
NEW
|
347,333 | $16,057,205 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ETON
ETON PHARMACEUT...
|
Healthcare | 0.56% | — |
#43
Prev: #—
|
3.7 |
—
|
308,101 | — |
NEW
|
308,101 | $15,864,120 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KIDS
ORTHOPEDIATRICS...
|
Healthcare | 0.56% | 0.48% |
#44
5
Prev: #49
|
0.7 |
—
|
-21,946 | -3.0% |
P
S
|
710,198 | $15,816,109 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORGO
ORGANOGENESIS H...
|
Healthcare | 0.55% | 0.85% |
#45
12
Prev: #33
|
2.2 |
—
|
1,160,000 | 11.4% |
P
S
|
11,300,951 | $15,482,303 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GRAL
GRAIL INC
|
Healthcare | 0.54% | — |
#46
Prev: #—
|
3.7 |
—
|
108,500 | — |
NEW
|
108,500 | $15,203,020 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.54% | 0.98% |
#47
17
Prev: #30
|
0.2 |
—
|
-256,382 | -49.8% |
P
S
|
258,897 | $15,176,542 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 0.48% | 0.63% |
#48
4
Prev: #44
|
0.2 |
—
|
-120,902 | -26.8% |
P
S
|
329,987 | $13,397,472 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AMRX
AMNEAL PHARMACE...
|
Healthcare | 0.47% | — |
#49
Prev: #—
|
3.7 |
—
|
658,000 | — |
NEW
|
658,000 | $13,252,120 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRLD
PRELUDE THERAPE...
|
Healthcare | 0.47% | 0.62% |
#50
5
Prev: #45
|
1.2 |
—
|
no change | no change |
P
S
|
3,378,378 | $13,209,458 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 124 holdings